Navigation Links
Global Bone Cement and Accessories Market Is Set to Expand from $630 Million in 2013 to Over $1 Billion by 2022
Date:9/3/2014

BURLINGTON, Mass., Sept. 3, 2014 /PRNewswire/ -- Decision Resources Group finds that the global market for bone cement and accessories will expand from $630 million in 2013 to over $1 billion by 2022. While the United States will continue to be the largest contributor of global revenues, the most growth will come from the rapidly expanding Brazilian, Indian and Chinese markets, where joint reconstruction volumes are increasing quickly and thus boosting demand for bone cement and accessories.

Other key findings from Decision Resources Group's coverage of the global bone cement and accessories market:

  • Impact of cementless implants: Although the bone cement market will be hampered by the use of cementless implants, the once rapid shift to cementless devices has slowed. Recent budget and reimbursement cuts have caused physicians to question whether the benefits of cementless implants justify their higher cost over cemented implants.
  • Premium-priced products: Despite pricing pressures, some higher-priced bone cement and accessory products will be increasingly adopted. For example, more expensive antibiotic bone cement is gaining popularity due to its ability to reduce the potential for infection. Higher-priced compatible and enclosed vacuum systems are also being adopted because they minimize the amount of monomer fumes in the operating room and reduce cement porosity.
  • Antibiotic bone cement in Japan: In 2014, the first antibiotic bone cement products—from Stryker and Biomet—entered the Japanese market, which will have a favorable impact on revenue growth. However, use of the products will be limited because they are only approved for very specific indications in Japan and there is a lack of awareness of antibiotic bone cement in the country.

Comments from Decision Resources Group Lead Analyst Deanna Edmunds:

  • "Stryker continues to lead the global market for bone cement and accessories, and the top players are all larger multinational companies that also sell related products, specifically reconstructive joint implants."
  • "The competitive landscape could see some change going forward. Zimmer's pending acquisition of Biomet could boost the combined company's position in the reconstructive implant space, which would have a positive impact on its position in the market for bone cement and accessories."

Additional Resources:

About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:
Decision Resources Group
Christopher Comfort
781-993-2597
ccomfort@dresourcesgroup.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36768LOGO


'/>"/>
SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Cambrex To Present At Rodman & Renshaw 16th Annual Global Investment Conference
2. CytoSorbents to Present at the 2014 Rodman & Renshaw Annual Global Investment Conference
3. Isis Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
4. RXi Pharmaceuticals to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
5. Relmada Therapeutics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th, 2014
6. Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology
7. Global Markets and Technologies for Molecular Imaging Devices
8. Bariatric Surgery: Global Markets for Services and Devices
9. Acute Heart Failure Global Clinical Trials Review, H2, 2014
10. Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden
11. Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months after ... is pleased to announce the appointment of three new ... Wynne , Dominic Jones-Phillips and James ... Tammy Wynne ... of market access writers. She has over ten years, ...
(Date:8/31/2017)... 2017 PM360,s annual Innovations Issue, published ... latest innovations happening across the industry. Established six years ... on providing a comprehensive look at the newest and ... most innovative companies, startups, divisions, products, services, and strategies ... "Everyone in this industry wants to do better—in ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... CTNext , Connecticut’s ... Awards (EIA), held this past Thursday night at The Space in Hamden. ... their innovative project ideas to a panel of judges for an opportunity to ...
(Date:9/19/2017)... ... September 19, 2017 , ... Presenting ... Benefit Administrators (SPBA) hosted “Expanding Your Success” with an educational emphasis. , ... focused on best practices for third party administrators (TPAs) related to health plan ...
(Date:9/19/2017)... ... September 19, 2017 , ... The Semper Fi Fund, one of the ... of a series of videos and a compelling documentary that provide unique insights and ... States as part of its ongoing mission. , Each of the videos focuses on ...
(Date:9/19/2017)... ... 19, 2017 , ... Public outrage over the toxins that exist in tap ... leaving the water industry itself to research, develop and ultimately supply consumers with healthy ... the field of natural alkaline water technologies, water filtration systems, ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... supplement developed by a neurosurgeon, has received a big bump in sales ... Brain Booster is currently available on the Wal-Mart Stores-owned Jet.com, StackedNutrtion.com, RonnieColemanNutrition.com, ...
Breaking Medicine News(10 mins):